Wound Care Biologics Market Research Report – Forecast to 2023

Global Wound Care Biologics Research Report: Information by Product Type (Biological Skin Substitutes, Topical Agents), by Wound Type (Surgical and Traumatic Wounds, Diabetic Foot Ulcer, Pressure Ulcers), End User (Hospitals, Clinics)—Forecast till 2023

ID: MRFR/MED/5101-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global wound care biologics market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 1.20 billion in 2017 and is projected to grow at a CAGR of 9.9% over the forecast period. Wound care biologics products create an active healing environment which allows the body to heal wound naturally. The wound care biologics are mainly used to the management of diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers.


The factors such as the increasing prevalence of chronic diseases and burn injuries, and increasing healthcare expenditure are expected to propel the growth of the market. According to the Centers for Disease Control and Prevention (CDC), in 2015, about 2.8 million people were hospitalized due to injuries. However, the high cost of treatment, lack of awareness, and poor education and training hamper the market growth over the forecast period.


Segmentation


The global wound care biologics market has been segmented into product type, wound type, and end user.


Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market in 2017.


The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.


The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Integra LifeSciences Corporation (US), Smith & Nephew (UK), Wright Medical (US), Mölnlycke Health Care AB (Sweden), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Marine Polymer Technologies, Inc. (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Organogenesis (US) are some of the key players in the global wound care biologics market.


Regional Market Summary


Global Wound Care Biologics Market Share (%), by Region, 2017


 


Source: Centers for Disease Control and Prevention (CDC), National Diabetes Statistics, and Annual Reports,


Geographically, the Americas is anticipated to dominate the global wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.


Europe is expected to hold the second largest position in the global wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.


The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.


The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.


Global Wound Care Biologics Market, by Product Type



  • Skin Substitute

  • Human Donor Tissue

  • Acellular animal-derived

  • Biosynthetic



  • Topical Agents


Global Wound Care Biologics Market, by Wound Type



  • Ulcers

  • Diabetic foot ulcers

  • Venous ulcers

  • Pressure ulcers

  • Other ulcers

  • Surgical and Traumatic Wounds

  • Burns


Global Wound Care Biologics Market, by End User



  • Hospitals

  • Clinics

  • Other End Users


Global Wound Care Biologics Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • The Middle East & Africa



  • Middle East

  • Africa


Intended Audience



  • Wound Care Biologics Manufacturers and Vendors

  • Various Research and Consulting Firms

  • Wound Care Biologics Distributors

  • Hospitals



Table of Contents:


Chapter 1. Report Prologue


Chapter 2. Market Introduction


2.1 Definition


2.2 Scope of the Study


2.2.1 Research Objective


2.2.2 Assumptions


2.2.3 Limitations


Chapter 3. Research Methodology


3.1 Introduction


3.2 Primary Research


3.3 Secondary Research


3.4 Market Size Estimation


Chapter 4. Market Dynamics


4.1 Drivers


4.2 Restraints


4.3 Opportunities


4.4 Challenges


4.5 Macroeconomic Indicators


4.6 Technology Trends & Assessment


Chapter 5. Market Factor Analysis


5.1 Porter’s Five Forces Analysis


5.1.1 Bargaining Power of Suppliers


5.1.2 Bargaining Power of Buyers


5.1.3 Threat of New Entrants


5.1.4 Threat of Substitutes


5.1.5 Intensity of Rivalry


5.2 Value Chain Analysis


5.3 Investment Feasibility Analysis


5.4 Pricing Analysis


Chapter 6. Global Wound Care Biologics Market, by Product Type


6.1 Introduction


6.2 Skin Substitute


6.2.1 Human Donor Tissue


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.2.2 Acellular Animal-derived


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.2.3 Biosynthetic


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


6.3 Topical Agents


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


Chapter 7. Global Wound Care Biologics Market, by Wound Type


7.1 Introduction


7.2 Ulcers


7.3.1 Diabetic Foot Ulcers


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.3.2 Venous Ulcers


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.3.3 Pressure Ulcers


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.3.4 Other Ulcers


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.3 Surgical and Traumatic Wounds


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


7.4 Burns


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


Chapter 8. Global Wound Care Biologics Market, by End User


8.1 Introduction


8.2 Hospitals


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


8.3 Clinics


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


8.4 Other End Users


Market Estimates & Forecast, by Region, 2018–2023


Market Estimates & Forecast, by Country, 2018–2023


Chapter 9. Global Wound Care Biologics Market, by Region


9.1 Introduction


9.2 Americas


9.2.1 North America


9.2.1.1 US


9.2.1.2 Canada


9.2.2 South America


9.3 Europe


9.3.1 Western Europe


9.3.1.1 Germany


9.3.1.2 France


9.3.1.3 Italy


9.3.1.4 Spain


9.3.1.5 UK


9.3.1.6 Rest of Western Europe


9.3.2 Eastern Europe


9.4 Asia-Pacific


9.4.1 Japan


9.4.2 China


9.4.3 India


9.4.4 Australia


9.4.5 South Korea


9.4.6 Rest of Asia-Pacific


9.5 Middle East & Africa


9.5.1 Middle East


9.5.2 Africa


Chapter 10. Company Landscape


10.1 Introduction


10.2 Market Share Analysis


10.3 Key Development & Strategies




Chapter 11. Company Profiles


11.1 Integra LifeSciences Corporation


11.1.1 Company Overview


11.1.2 Product Overview


11.1.3 Financials Overview


11.1.4 Key Developments


11.1.5 SWOT Analysis


11.2 Smith & Nephew


11.2.1 Company Overview


11.2.2 Product Overview


11.2.3 Financial Overview


11.2.4 Key Developments


11.2.5 SWOT Analysis


11.3 Wright Medical


11.3.1 Company Overview


11.3.2 Product Overview


11.3.3 Financial Overview


11.3.4 Key Development


11.3.5 SWOT Analysis


11.4 Mölnlycke Health Care AB


11.4.1 Company Overview


11.4.2 Product Overview


11.4.3 Financial Overview


11.4.4 Key Development


11.4.5 SWOT Analysis


11.5 MiMedx Group


11.5.1 Company Overview


11.5.2 Product Overview


11.5.3 Financial overview


11.5.4 Key Developments


11.5.5 SWOT Analysis


11.6 Vericel Corporation


11.6.1 Company Overview


11.6.2 Product Overview


11.6.3 Financial Overview


11.6.4 Key Developments


11.6.5 SWOT Analysis


11.7 Anika Therapeutics


11.7.1 Overview


11.7.2 Product Overview


11.7.3 Financial Overview


11.7.4 Key Developments


11.7.5 SWOT Analysis




11.8 Osiris Therapeutics


11.8.1 Overview


11.8.2 Product Overview


11.8.3 Financials


11.8.4 Key Developments


11.8.5 SWOT Analysis


11.9 Organogenesis


11.9.1 Overview


11.9.2 Product Overview


11.9.3 Financials


11.9.4 Key Developments


11.9.5 SWOT Analysis


11.10 Solsys Medical


11.10.1 Overview


11.10.2 Product Overview


11.10.3 Financials


11.10.4 Key Developments


11.10.5 SWOT Analysis


11.11 Others


Chapter 12 MRFR Conclusion


12.1 Key Findings


12.1.1 From CEO’s Viewpoint


12.1.2 Unmet Needs of the Market


12.2 Key Companies to Watch


12.3 Predictions for the Wound Care Biologics Industry


Chapter 13. Appendix


LIST OF TABLES


Table 1 Global Wound Care Biologics Market Synopsis, 2018–2023


Table 2 Global Wound Care Biologics Market Estimates and Forecast, 2018–2023


(USD Million)


Table 3 Global Wound Care Biologics Market, by Region, 2018–2023 (USD Million)


Table 4 Global Wound Care Biologics Market, by Product Type, 2018–2023 (USD Million)


Table 5 Global Wound Care Biologics Market, by Wound Type, 2018–2023 (USD


Million)


Table 7 Global Wound Care Biologics Market, by End User, 2018–2023 (USD


Million)


Table 8 North America: Wound Care Biologics Market, by Product Type, 2018–2023


(USD Million)


Table 9 North America: Wound Care Biologics Market, by Wound Type, 2018–2023


(USD Million)


Table 10 North America: Wound Care Biologics Market, by End User, 2018–2023


(USD Million)


Table 11 US: Wound Care Biologics Market, by Product Type, 2018–2023


(USD Million)


Table 12 US: Wound Care Biologics Market, by Wound Type, 2018–2023


(USD Million)


Table 13 US: Wound Care Biologics Market, by End User, 2018–2023 (USD Million)


Table 14 Canada: Wound Care Biologics Market, by Product Type, 2018–2023 (USD


Million)


Table 15 Canada: Wound Care Biologics Market, by Wound Type, 2018–2023 (USD


Million)


Table 16 Canada: Wound Care Biologics Market, by End User, 2018–2023 (USD


Million)


Table 17 South America: Wound Care Biologics Market, by Product Type, 2018–2023


(USD Million)


Table 18 South America: Wound Care Biologics Market, by Wound Type, 2018–2023


(USD Million)


Table 19 South America: Wound Care Biologics Market, by End User, 2018–2023


(USD Million)


Table 20 Europe: Wound Care Biologics Market, by Product Type, 2018–2023 (USD


Million)


Table 21 Europe: Wound Care Biologics Market, by Wound Type, 2018–2023 (USD


Million)


Table 22 Europe: Wound Care Biologics Market, by End User, 2018–2023 (USD


Million)


Table 23 Western Europe: Wound Care Biologics Market, by Product Type, 2018–


2023 (USD Million)


Table 24 Western Europe: Wound Care Biologics Market, by Wound Type, 2018–


2023 (USD Million)


Table 25 Western Europe: Wound Care Biologics Market, by End User, 2018–2023


(USD Million)


Table 26 Eastern Europe: Wound Care Biologics Market, by Product Type, 2018–


2023 (USD Million)


Table 27 Eastern Europe: Wound Care Biologics Market, by Wound Type, 2018–2023


(USD Million)


Table 28 Eastern Europe: Wound Care Biologics Market, by End User, 2018–2023


(USD Million)


Table 29 Asia-Pacific: Wound Care Biologics Market, by Product Type, 2018–2023


(USD Million)


Table 30 Asia-Pacific: Wound Care Biologics Market, by Wound Type, 2018–2023


(USD Million)


Table 31 Asia-Pacific: Wound Care Biologics Market, by End User, 2018–2023 (USD


Million)


Table 32 Middle East & Africa: Wound Care Biologics Market, by Product Type,


2018–2023 (USD Million)


Table 33 Middle East & Africa: Wound Care Biologics Market, by Wound Type, 2018–


2023 (USD Million)


Table 34 Middle East & Africa: Wound Care Biologics Market, by End User, 2018–


2023 (USD Million)


LIST OF FIGURES


Figure 1 Research Process


Figure 2 Segmentation for Global Wound Care Biologics Market


Figure 3 Segmentation Market Dynamics for Global Wound Care Biologics Market


Figure 4 Global Wound Care Biologics Market Share, by Product Type, 2017


Figure 5 Global Wound Care Biologics Market Share, by Wound Type, 2017


Figure 6 Global Wound Care Biologics Market Share, by End User, 2017


Figure 7 Global Wound Care Biologics Market Share, by Region, 2017


Figure 8 North America: Wound Care Biologics Market Share, by Country, 2017


Figure 9 Europe: Wound Care Biologics Market Share, by Country, 2017


Figure 10 Asia-Pacific: Wound Care Biologics Market Share, by Country, 2017


Figure 11 Middle East & Africa: Wound Care Biologics Market Share, by Country, 201


Figure 12 Global Wound Care Biologics Market: Company Share Analysis, 2017 (%)


Figure 13 Integra LifeSciences Corporation: Key Financials


Figure 14 Integra LifeSciences Corporation: Segmental Revenue


Figure 15 Integra LifeSciences Corporation: Geographical Revenue


Figure 16 Smith & Nephew: Key Financials


Figure 17 Smith & Nephew: Segmental Revenue


Figure 18 Smith & Nephew: Geographical Revenue


Figure 19 Wright Medical: Key Financials


Figure 20 Wright Medical: Segmental Revenue


Figure 21 Wright Medical: Geographical Revenue


Figure 22 Mölnlycke Health Care AB: Key Financials


Figure 23 Mölnlycke Health Care AB: Segmental Revenue


Figure 24 Mölnlycke Health Care AB: Geographical Revenue


Figure 25 MiMedx Group: Key Financials


Figure 26 MiMedx Group: Segmental Revenue


Figure 27 MiMedx Group. Geographical Revenue


Figure 28 Vericel Corporation: Key Financials


Figure 29 Vericel Corporation: Segmental Revenue


Figure 30 Vericel Corporation: Geographical Revenue


Figure 31 Anika Therapeutics: Key Financials


Figure 32 Anika Therapeutics: Segmental Revenue


Figure 33 Anika Therapeutics: Geographical Revenue


Figure 34 Osiris Therapeutics: Key Financials


Figure 35 Osiris Therapeutics: Segmental Revenue


Figure 36 Osiris Therapeutics: Geographical Revenue


Figure 37 Organogenesis: Key Financials


Figure 38 Organogenesis: Segmental Revenue


Figure 39 Organogenesis: Geographical Revenue


Figure 40 Solsys Medical : Key Financials


Figure 41 Solsys Medical: Segmental Revenue


Figure 42 Solsys Medical: Geographical Revenue


Figure 43 ACell : Key Financials


Figure 44 ACell : Segmental Revenue


Figure 45 ACell : Geographical Revenue


Figure 46 Kerecis : Key Financials


Figure 47 Kerecis : Segmental Revenue


Figure 48 Kerecis : Geographical Revenue